Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and Obesity
Spinal muscular atrophy is a genetic neuromuscular disease characterised by muscle atrophy, hypotonia, weakness, and progressive paralysis. Usually, these patients display increased fat mass deposition and reductions in fat-free mass and resting energy expenditure—an unfavourable condition that faci...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2018/4058429 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549442296741888 |
|---|---|
| author | Marwan El Ghoch Paola Vittoria Bazzani Simona Calugi Riccardo Dalle Grave |
| author_facet | Marwan El Ghoch Paola Vittoria Bazzani Simona Calugi Riccardo Dalle Grave |
| author_sort | Marwan El Ghoch |
| collection | DOAJ |
| description | Spinal muscular atrophy is a genetic neuromuscular disease characterised by muscle atrophy, hypotonia, weakness, and progressive paralysis. Usually, these patients display increased fat mass deposition and reductions in fat-free mass and resting energy expenditure—an unfavourable condition that facilitates the development of obesity. However, weight management of these patients remains poorly described. Hence, the aim of this case report was to describe the clinical presentation and weight management of a 31-year-old male patient with spinal muscular atrophy type III, class I obesity, and metabolic syndrome treated for 1 year by means of a personalised multistep cognitive-behavioural treatment for obesity. The treatment produced a weight loss of 7.2 kg (7.1%), which was associated with a marked improvement in both the patient’s self-reported general conditions and obesity-related cardiometabolic profile, and no adverse effects in terms of spinal muscular atrophy (i.e., reductions in fat-free mass or resting energy expenditure). |
| format | Article |
| id | doaj-art-5e37d1b386bd45ffbf907e3e97bf2d48 |
| institution | Kabale University |
| issn | 1687-9627 1687-9635 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Medicine |
| spelling | doaj-art-5e37d1b386bd45ffbf907e3e97bf2d482025-02-03T06:11:16ZengWileyCase Reports in Medicine1687-96271687-96352018-01-01201810.1155/2018/40584294058429Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and ObesityMarwan El Ghoch0Paola Vittoria Bazzani1Simona Calugi2Riccardo Dalle Grave3Department of Eating and Weight Disorders, Villa Garda Hospital, Garda, Verona, ItalyDepartment of Radiology, Villa Garda Hospital, Garda, Verona, ItalyDepartment of Eating and Weight Disorders, Villa Garda Hospital, Garda, Verona, ItalyDepartment of Eating and Weight Disorders, Villa Garda Hospital, Garda, Verona, ItalySpinal muscular atrophy is a genetic neuromuscular disease characterised by muscle atrophy, hypotonia, weakness, and progressive paralysis. Usually, these patients display increased fat mass deposition and reductions in fat-free mass and resting energy expenditure—an unfavourable condition that facilitates the development of obesity. However, weight management of these patients remains poorly described. Hence, the aim of this case report was to describe the clinical presentation and weight management of a 31-year-old male patient with spinal muscular atrophy type III, class I obesity, and metabolic syndrome treated for 1 year by means of a personalised multistep cognitive-behavioural treatment for obesity. The treatment produced a weight loss of 7.2 kg (7.1%), which was associated with a marked improvement in both the patient’s self-reported general conditions and obesity-related cardiometabolic profile, and no adverse effects in terms of spinal muscular atrophy (i.e., reductions in fat-free mass or resting energy expenditure).http://dx.doi.org/10.1155/2018/4058429 |
| spellingShingle | Marwan El Ghoch Paola Vittoria Bazzani Simona Calugi Riccardo Dalle Grave Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and Obesity Case Reports in Medicine |
| title | Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and Obesity |
| title_full | Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and Obesity |
| title_fullStr | Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and Obesity |
| title_full_unstemmed | Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and Obesity |
| title_short | Weight-Loss Cognitive-Behavioural Treatment and Essential Amino Acid Supplementation in a Patient with Spinal Muscular Atrophy and Obesity |
| title_sort | weight loss cognitive behavioural treatment and essential amino acid supplementation in a patient with spinal muscular atrophy and obesity |
| url | http://dx.doi.org/10.1155/2018/4058429 |
| work_keys_str_mv | AT marwanelghoch weightlosscognitivebehaviouraltreatmentandessentialaminoacidsupplementationinapatientwithspinalmuscularatrophyandobesity AT paolavittoriabazzani weightlosscognitivebehaviouraltreatmentandessentialaminoacidsupplementationinapatientwithspinalmuscularatrophyandobesity AT simonacalugi weightlosscognitivebehaviouraltreatmentandessentialaminoacidsupplementationinapatientwithspinalmuscularatrophyandobesity AT riccardodallegrave weightlosscognitivebehaviouraltreatmentandessentialaminoacidsupplementationinapatientwithspinalmuscularatrophyandobesity |